AstraZeneca launches Eculizumab in India EP News Bureau Sep 10, 2025 It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…
Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology… EP News Bureau Nov 8, 2023 Total transaction value of the divestment is Rs 3,660 million, inclusive of working capital conveyed as part of the deal
JBCPL forays into nephrology segment in India with new division called RENOVA EP News Bureau May 6, 2021 JBCPL to launch seven products in the division that will focus on the management of hypertension in Chronic Kidney Disease to…
